Incannex Healthcare Inc ADR (IXHL)

$0.28 -0.01 (-4.87%)
Market Cap 107.19M
Revenue (ttm) 90,000.00
Net Income (ttm) -46.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -52,100.00%
Debt to Equity Ratio 0.00
Volume 7,123,228
Avg Vol 15,616,286
Day's Range N/A - N/A
Shares Out 346.23M
Stochastic %K 19%
Beta 7.46
Analysts Hold
Price Target N/A

Company Profile

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety diso...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 61 4 0984 0786
Address:
8 Century Circuit, Suite 105 Norwest, Sydney, Australia
macdub8
macdub8 Feb. 3 at 9:23 PM
$IXHL Lilly earnings call tomorrow (we know Lilly are ultra-aggressive with their intended expansions into OSA and i see a partnership supporting and not cannablising their OSA medication).
0 · Reply
macdub8
macdub8 Feb. 3 at 9:14 PM
$IXHL this price action is wild. There has to be something here
1 · Reply
CashisKing_
CashisKing_ Feb. 3 at 9:14 PM
$IXHL drop the news Joel, we are ready!
0 · Reply
CashisKing_
CashisKing_ Feb. 3 at 9:09 PM
$IXHL
0 · Reply
IldijanaMM
IldijanaMM Feb. 3 at 9:09 PM
$IXHL The real accumulation was at 0.45-0.47$ after news Fast Track when 280M shares was traded!
0 · Reply
Affen
Affen Feb. 3 at 9:08 PM
$IXHL I block bears that spam the board without anything to add. Makes for a much nicer experience
0 · Reply
Nawaf643
Nawaf643 Feb. 3 at 9:07 PM
$IXHL Tomorrow is where my prediction begins — buckle up! 🥶
0 · Reply
Mareux
Mareux Feb. 3 at 9:06 PM
$IXHL same recovery as yesterday, very interesting.
0 · Reply
Affen
Affen Feb. 3 at 9:05 PM
$IXHL tomorrow morning 630 am would be a dream come true but I'll be patient if it doesn't drop. Wednesday or Thursday would be the most bullish days to drop it though imo it would mean everything is going perfectly.
1 · Reply
stockro1
stockro1 Feb. 3 at 9:01 PM
$IXHL I bought 3k more at .2770. Very good risk to reward prices here. Could easily move 50-100% on volume and news.
1 · Reply
Latest News on IXHL
Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board

Jan 29, 2026, 8:00 AM EST - 5 days ago

Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board

Incannex Healthcare Announces Formation of Clinical Advisory Board for PSX-001 Program

Jan 22, 2026, 8:00 AM EST - 12 days ago

Incannex Healthcare Announces Formation of Clinical Advisory Board for PSX-001 Program

Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards

Jan 15, 2026, 8:00 AM EST - 19 days ago

Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards

Incannex Healthcare Delivers Transformational 2025 Progress and Outlines Well-Funded Outlook for 2026

Jan 14, 2026, 8:00 AM EST - 20 days ago

Incannex Healthcare Delivers Transformational 2025 Progress and Outlines Well-Funded Outlook for 2026

Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA)

Dec 3, 2025, 8:00 AM EST - 2 months ago

Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA)

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2026

Nov 20, 2025, 9:34 AM EST - 2 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2026

Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus

Oct 30, 2025, 8:00 AM EDT - 3 months ago

Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus

Incannex Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

Oct 22, 2025, 8:00 AM EDT - 3 months ago

Incannex Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder

Aug 26, 2025, 8:00 AM EDT - 5 months ago

Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder

Incannex Healthcare Authorizes $20 Million Share Repurchase Program

Aug 22, 2025, 8:00 AM EDT - 5 months ago

Incannex Healthcare Authorizes $20 Million Share Repurchase Program

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update

Aug 19, 2025, 4:29 PM EDT - 6 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update

Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea

Aug 8, 2025, 8:00 AM EDT - 6 months ago

Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea

Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term

Jul 31, 2025, 8:00 AM EDT - 6 months ago

Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term

Nano-Cap Incannex's Sleep Apnea Candidate Shows Effectiveness And Safety In Mid-Stage Trial

Jul 30, 2025, 10:10 AM EDT - 6 months ago

Nano-Cap Incannex's Sleep Apnea Candidate Shows Effectiveness And Safety In Mid-Stage Trial

Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X

Jul 30, 2025, 8:00 AM EDT - 6 months ago

Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo

Jul 25, 2025, 7:30 AM EDT - 6 months ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Jun 24, 2025, 7:30 AM EDT - 8 months ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X

Jun 18, 2025, 7:30 AM EDT - 8 months ago

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

Jun 17, 2025, 7:30 AM EDT - 8 months ago

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Jun 12, 2025, 7:30 AM EDT - 8 months ago

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

Jun 3, 2025, 7:30 AM EDT - 8 months ago

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

May 29, 2025, 7:30 AM EDT - 8 months ago

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025

May 28, 2025, 4:21 PM EDT - 8 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

May 28, 2025, 7:00 AM EDT - 8 months ago

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution

May 20, 2025, 7:30 AM EDT - 9 months ago

Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

May 16, 2025, 9:00 AM EDT - 9 months ago

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

May 15, 2025, 8:00 AM EDT - 9 months ago

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On?

May 14, 2025, 4:14 PM EDT - 9 months ago

Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On?

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

May 14, 2025, 8:00 AM EDT - 9 months ago

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Apr 3, 2025, 7:30 AM EDT - 10 months ago

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

Mar 7, 2025, 2:10 PM EST - 11 months ago

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Feb 18, 2025, 5:51 PM EST - 1 year ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

Feb 14, 2025, 7:30 AM EST - 1 year ago

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board

Feb 4, 2025, 9:15 AM EST - 1 year ago

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

Jan 23, 2025, 7:30 AM EST - 1 year ago

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025

Dec 2, 2024, 4:48 PM EST - 1 year ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

Nov 14, 2024, 4:05 PM EST - 1 year ago

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer

Oct 24, 2024, 7:30 AM EDT - 1 year ago

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer

Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL)

Oct 2, 2024, 4:50 PM EDT - 1 year ago

Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL)

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates

Sep 30, 2024, 4:01 PM EDT - 1 year ago

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates

Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives

Sep 9, 2024, 8:00 AM EDT - 1 year ago

Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed

Aug 5, 2024, 7:30 AM EDT - 1 year ago

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X

Jul 30, 2024, 7:30 AM EDT - 1 year ago

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

May 30, 2024, 7:30 AM EDT - 1 year ago

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder

May 7, 2024, 7:30 AM EDT - 1 year ago

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder

Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD)

May 1, 2024, 2:33 PM EDT - 1 year ago

Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD)

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

Feb 16, 2024, 7:30 AM EST - 2 years ago

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

Clarion Clinics Open for Psychedelic-Assisted Treatments

Feb 1, 2024, 7:30 AM EST - 2 years ago

Clarion Clinics Open for Psychedelic-Assisted Treatments

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

Jan 24, 2024, 4:05 PM EST - 2 years ago

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences

Jan 18, 2024, 8:22 AM EST - 2 years ago

Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences

macdub8
macdub8 Feb. 3 at 9:23 PM
$IXHL Lilly earnings call tomorrow (we know Lilly are ultra-aggressive with their intended expansions into OSA and i see a partnership supporting and not cannablising their OSA medication).
0 · Reply
macdub8
macdub8 Feb. 3 at 9:14 PM
$IXHL this price action is wild. There has to be something here
1 · Reply
CashisKing_
CashisKing_ Feb. 3 at 9:14 PM
$IXHL drop the news Joel, we are ready!
0 · Reply
CashisKing_
CashisKing_ Feb. 3 at 9:09 PM
$IXHL
0 · Reply
IldijanaMM
IldijanaMM Feb. 3 at 9:09 PM
$IXHL The real accumulation was at 0.45-0.47$ after news Fast Track when 280M shares was traded!
0 · Reply
Affen
Affen Feb. 3 at 9:08 PM
$IXHL I block bears that spam the board without anything to add. Makes for a much nicer experience
0 · Reply
Nawaf643
Nawaf643 Feb. 3 at 9:07 PM
$IXHL Tomorrow is where my prediction begins — buckle up! 🥶
0 · Reply
Mareux
Mareux Feb. 3 at 9:06 PM
$IXHL same recovery as yesterday, very interesting.
0 · Reply
Affen
Affen Feb. 3 at 9:05 PM
$IXHL tomorrow morning 630 am would be a dream come true but I'll be patient if it doesn't drop. Wednesday or Thursday would be the most bullish days to drop it though imo it would mean everything is going perfectly.
1 · Reply
stockro1
stockro1 Feb. 3 at 9:01 PM
$IXHL I bought 3k more at .2770. Very good risk to reward prices here. Could easily move 50-100% on volume and news.
1 · Reply
bound4glory
bound4glory Feb. 3 at 9:00 PM
$IXHL Nice recovery.
0 · Reply
IldijanaMM
IldijanaMM Feb. 3 at 8:59 PM
$IXHL Things can move quick here at worst stock on market 😉😂
1 · Reply
200cellphones
200cellphones Feb. 3 at 8:58 PM
$IXHL
0 · Reply
munzy1
munzy1 Feb. 3 at 8:57 PM
$IXHL hmmm recovery
0 · Reply
IldijanaMM
IldijanaMM Feb. 3 at 8:57 PM
$IXHL Send it 🚀
0 · Reply
IldijanaMM
IldijanaMM Feb. 3 at 8:53 PM
$IXHL What people don’t remember here is the day after a low volume day this exploded into next day with 1.5B shares traded Sentiment will turn our way and catalyst are coming before extension period end
1 · Reply
meanrebel
meanrebel Feb. 3 at 8:52 PM
$IXHL DROP IT!!!!
0 · Reply
Nawaf643
Nawaf643 Feb. 3 at 8:50 PM
$IXHL Tik tak ⏳🥶
0 · Reply
Dalder
Dalder Feb. 3 at 8:38 PM
$IXHL Back at it again. Won’t let buy now. Just bought 5k last week now can’t 😕
1 · Reply
It_S_Me
It_S_Me Feb. 3 at 8:38 PM
$IXHL
0 · Reply
IldijanaMM
IldijanaMM Feb. 3 at 8:36 PM
$IXHL We wait for EOP2 for IHL-42X since it’s in phase 2/3 results, they can use data from the phase in to phase 3 for a shorter phase 3 and the company have cash to run phase 3 self. When EOP2 comes and guidelines are shorter we gonna see price rocket to 5-6$ same day 😎
2 · Reply
Zukarude
Zukarude Feb. 3 at 8:34 PM
$IXHL bullish long-term. Cannot fight sentiment. We need meaningful guidance.
1 · Reply